117 related articles for article (PubMed ID: 2632064)
1. Increased transport of theophylline into gastrointestinal lumen and gastrointestinal dialysis by activated charcoal in rats with hepatic cirrhosis.
Arimori K; Wakayama K; Nakano M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3148-9. PubMed ID: 2632064
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
Arimori K; Nakano M
J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
[TBL] [Abstract][Full Text] [Related]
3. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
Arimori K; Nakano M
J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
[TBL] [Abstract][Full Text] [Related]
4. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
Arimori K; Nakano M
J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
[TBL] [Abstract][Full Text] [Related]
5. Transport of theophylline from blood to the intestinal lumen following i.v. administration to rats.
Arimori K; Nakano M
J Pharmacobiodyn; 1985 Apr; 8(4):324-7. PubMed ID: 4032222
[TBL] [Abstract][Full Text] [Related]
6. The intestinal dialysis of intravenously administered phenytoin by oral activated charcoal in rats.
Arimori K; Nakano M
J Pharmacobiodyn; 1987 Apr; 10(4):157-65. PubMed ID: 3656062
[TBL] [Abstract][Full Text] [Related]
7. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure.
Arimori K; Nakano M
J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613
[TBL] [Abstract][Full Text] [Related]
8. Transport of furosemide into the intestinal lumen and the lack of effect of gastrointestinal dialysis by charcoal in rats with acute renal failure.
Arimori K; Nakano M
J Pharmacobiodyn; 1988 Jan; 11(1):1-8. PubMed ID: 3385600
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestine.
de Vries MH; Rademaker CM; Geerlings C; Van Dijk A; Noordhoek J
J Pharm Pharmacol; 1989 Aug; 41(8):528-33. PubMed ID: 2571696
[TBL] [Abstract][Full Text] [Related]
10. Potential pharmacodynamic effect of charcoal on theophylline neurotoxicity in normal rats.
Hoffman A
Pharmacol Biochem Behav; 1992 Oct; 43(2):621-3. PubMed ID: 1438500
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of theophylline and phenobarbital during peritoneal dialysis compared with intestinal dialysis in rats.
Arimori K; Hashimoto Y; Nakano M
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3177-9. PubMed ID: 2085904
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intestinal and peritoneal dialysis of theophylline and phenobarbitone in rats.
Arimori K; Hashimoto Y; Nakano M
J Pharm Pharmacol; 1990 Oct; 42(10):726-8. PubMed ID: 1982147
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
Hoffman A; Levy G
Pharm Res; 1990 Mar; 7(3):242-6. PubMed ID: 2339096
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of theophylline clearance in gastrointestinal dialysis with charcoal.
Huang JD
J Pharm Sci; 1987 Jul; 76(7):525-7. PubMed ID: 3668813
[TBL] [Abstract][Full Text] [Related]
15. Effect of activated charcoal and atropine on absorption and/or exsorption of organophosphorus compounds in rats.
Tomimaru A; Arimori K; Inotsume N; Nakano M
J Pharm Pharmacol; 1996 Apr; 48(4):351-6. PubMed ID: 8794982
[TBL] [Abstract][Full Text] [Related]
16. Role of unstirred water layer in the exsorption of quinidine.
Huang JD
J Pharm Pharmacol; 1990 Jun; 42(6):435-7. PubMed ID: 1979626
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of orally administered activated charcoal on intestinal dialysis of intravenously administered M79175, an aldose reductase inhibitor, in rats.
Arimori K; Mishima M; Iwaoku R; Nakano M
J Pharmacobiodyn; 1987 Jun; 10(6):243-9. PubMed ID: 3118006
[TBL] [Abstract][Full Text] [Related]
18. Prevention of drug absorption in simulated theophylline overdose.
Minton NA; Henry JA
J Toxicol Clin Toxicol; 1995; 33(1):43-9. PubMed ID: 7837312
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics.
Mckinnon RS; Desmond PV; Harman PJ; Kamm M; Ghabrial H; Martin CJ; Mashford ML
J Pharm Pharmacol; 1987 Jul; 39(7):522-5. PubMed ID: 2886620
[TBL] [Abstract][Full Text] [Related]
20. Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.
Zhang D; Frost CE; He K; Rodrigues AD; Wang X; Wang L; Goosen TC; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):906-15. PubMed ID: 23386703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
